Skip to content
Fencer Vulns
critical 9.9

CVE-2026-45661 json

Dokploy: Remote Code Execution through Path Traversal

published 2026-05-29 5 mo ago modified 2026-10-06 33 d ago also EUVD-2026-33352

cvss
9.9
version 3.1, CNA
cisa kev
Not listed
not in CISA's catalog
epss
0.8%
EPSS 0.8% chance of exploitation in 30 days, percentile 57%
public exploits
0
none known

Summary

Dokploy is a free, self-hostable Platform as a Service (PaaS). In 0.26.5 and earlier, a critical path traversal vulnerability exists in Dokploy v0.26.5 that allows authenticated users to write arbitrary files to the filesystem during application deployment. When combined with Dokploy's remote server deployment feature, this vulnerability enables arbitrary file write to remote server filesystems, automatic remote code execution via cron jobs, complete server compromise, data exfiltration without user interaction, and persistent backdoor installation. This vulnerability bypasses all container isolation on remote server deployments.

CISA SSVC

Exploitation
Proof of concept is public
Automatable
no
Technical impact
total
Assessed
5 mo ago

Exploit prediction

0.81% chance of exploitation in the next 30 days, higher than 57% of all scored CVEs (FIRST EPSS, 2026-11-08).

Exploits and checks

  • github.com https://github.com/Dokploy/dokploy/security/advisories/GHSA-66v7-g3fh-47h3 referenced PoC, tagged "exploit" by a source, unverified

CVSS scores

assigned by version score vector
CNA 3.1 9.9 CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H

Affected products

  • Dokploy dokploy

Classification

Weakness
  • CWE-22 Improper Limitation of a Pathname to a Restricted Directory
  • CWE-35 Path Traversal: '.../...//'

References

Sources

Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.

CPEs and fixed versions use Anchore's correction of NVD's data: Added CPE configurations because not yet analyzed by NVD.